Detection of mCRPC in ADT Naïve

Podcast with Dr. Adam Kibel, summarizing the poster "Metastatic Disease Detection is an Important Cause of Screen Failures in a Phase II Trial Evaluating the Optimal Sequence of Androgen Deprivation Therapy and Sipuleucel-T in Hormone-Naïve Patients with Biochemically-Recurrent Prostate Cancer (BRPC)" presented at the European Cancer Congress (ECCO) in Amsterdam, September 29 to October 1, 2013

This poster presents a data analysis from the Phase II study that indicated a high frequency of radiographic metastatic disease in the setting of hormone-naïve BRPC, which highlights the importance of screening for metastases in this early-stage patient population.

Click HERE to read the abstract and poster

Dr. Kibel - BIO



Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.